Current landscape of drug induced retinal vasculitis
Sivaraman Bala Murugan, Aneena Anna Thomas, Rakshita Deepak Kene, Aditya Rajan, Anup Kelgaonkar, Vedhanayagi Rajesh, Anjana Somanath, Padmamalini Mahendradas, Gokulvasanth Deivasenathipathi, Parthopratim Dutta Majumder · 2026
Read Current landscape of drug induced retinal vasculitis by Sivaraman Bala Murugan, Aneena Anna Thomas, Rakshita Deepak Kene, Aditya Rajan, Anup Kelgaonkar, Vedhanayagi Rajesh, Anjana Somanath, Padmamalini Mahendradas, Gokulvasanth Deivasenathipathi, Parthopratim Dutta Majumder (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634021.txt.
Description
Drug-induced retinal vasculitis (DIRV), a complex diagnostic entity, masquerades as infectious or primary autoimmune diseases. Delineating them is a daunting task. This update aims to consolidate clinical evidence focussing on characteristic “vascular signatures” using advanced multimodal imaging tools. Type III (immune complex-mediated) and Type IV (T-cell-mediated) hypersensitivity pathways were involved in diverse range of drugs causing DRIV.
Catalog record
| CREATOR | Sivaraman Bala Murugan, Aneena Anna Thomas, Rakshita Deepak Kene, Aditya Rajan, Anup Kelgaonkar, Vedhanayagi Rajesh, Anjana Somanath, Padmamalini Mahendradas, Gokulvasanth Deivasenathipathi, Parthopratim Dutta Majumder |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |